Guoguang Shao

机构：Jilin University, First Hospital of Jilin University · ORCID：0000-0001-8791-6545

发表论文 33 篇 · 总被引 503 次 · h-index 13

代表论文

• Erratum: MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2. (2017 · PubMed · 被引 69)
• Clinical guidelines on perioperative management strategies for enhanced recovery after lung surgery (2019 · Translational Lung Cancer Research · 被引 41)
• [Retracted] miR‑154 inhibits migration and invasion of human non‑small cell lung cancer by targeting ZEB2 (2021 · Oncology Letters · 被引 40)
• miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2 (2016 · Oncology Letters · 被引 40)
• Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial (2022 · Journal of Cancer Research and Clinical Oncology · 被引 39)
• Sanguinarine-induced apoptosis in lung adenocarcinoma cells is dependent on reactive oxygen species production and endoplasmic reticulum stress (2015 · Oncology Reports · 被引 39)